Gara Jalqabaatti › Lymphoma Follicular › Washington
Qorannoo klinikaalii Lymphoma Follicular Washington keessatti
Qorannoo 19 Lymphoma Follicular f Washington keessatti hirmaatuu jiru.
Magaalota Washington keessatti
Takkalaa qorannoo (Ingiliffa)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05006716A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Swedish Cancer Institute (SCI), Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Tacoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06549595Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Northwest Medical Specialties, Tacoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06784752SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Fred Hutch Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT06442475A Study of ARC-02 in B-cell NHL
- Summit Cancer Centers - North Spokane, Spokane
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
- Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT06948786Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
6 Months · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT04195633A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Local Institution - 0143, Vancouver
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT06911502Study of SGR-1505 in Mature B-Cell Neoplasms
- Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
- University of Washington-Seattle Cancer Care Alliance, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT04669171SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Swedish Cancer Institute, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2025 · NCT05780034Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
- University of Washington Medical Center, Seattle
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Gur-2021 · NCT02537769Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.